{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:58Z","timestamp":1786119538708,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1097\/mjt.0b013e3181d860f6","type":"journal-article","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T02:52:03Z","timestamp":1273546323000},"page":"e261-e263","source":"Crossref","is-referenced-by-count":5,"title":["Hand\u2013Foot Hyperpigmentation Skin Lesions Associated With Combination Gemcitabine\u2013Carboplatin (GemCarbo) Therapy"],"prefix":"10.1097","volume":"18","author":[{"given":"Roman L","family":"Kleynberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz A","family":"Sofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha T","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210202","first-page":"4417","article-title":"Evaluation of the antitumor activity of gemcitabine.","volume":"50","author":"Hertel","year":"1990","journal-title":"Cancer Res"},{"key":"R2-19-20210202","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2001.07.001","article-title":"Gemcitabine-associated scleroderma-like changes of the lower extremities.","volume":"51","author":"Bessis","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R3-19-20210202","first-page":"32","article-title":"Gemcitabine safety overview.","volume":"23","author":"Green","year":"1996","journal-title":"Semin Oncol"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1200\/JCO.1994.12.9.1821","article-title":"Single-agent activity of weekly gemcitabine in advanced non-small cell lung cancer: a phase II study.","volume":"12","author":"Anderson","year":"1994","journal-title":"J Clin Oncol"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2002.00485.x","article-title":"Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma.","volume":"16","author":"Kuku","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00001813-200001000-00003","article-title":"Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabinea report of three cases.","volume":"11","author":"Brandes","year":"2000","journal-title":"Anticancer Drugs"},{"key":"R7-19-20210202","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1345\/aph.10268","article-title":"Linear immunoglobulin a bullous dermatosis induced by gemcitabine.","volume":"35","author":"del Pozo","year":"2001","journal-title":"Ann Pharmacother"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.lungcan.2007.01.008","article-title":"Paraneoplastic syndrome of non-small cell lung carcinoma: a case with pancytopenia, leukocytoclastic vasculitis, and hypertrophic osteoarthropathy.","volume":"56","author":"Cosar-Alas","year":"2007","journal-title":"Lung Cancer"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/000331970105200909","article-title":"Squamous cell carcinoma of the lung presenting with cutaneous leukocytoclastic vasculitis: a case report.","volume":"52","author":"Odeh","year":"2001","journal-title":"Angiology"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1365-2133.2001.t01-1-04461.x","article-title":"Gemcitabine-associated CD8+ CD30+ pseudolymphoma.","volume":"145","author":"Marucci","year":"2001","journal-title":"Br J Dermatol"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.seminoncol.2005.11.004","article-title":"Dermatologic toxicity of chemotherapeutic agents.","volume":"33","author":"Payne","year":"2006","journal-title":"Semin Oncol"},{"key":"R12-19-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ijgc-00009577-200501000-00003","article-title":"Carboplatin hypersensitivity.","volume":"15","author":"Sliesoraitis","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000232315","article-title":"Toxic epidermal necrolysis related to pemetrexed and carboplatin with vitamin B12 and folic acid supplementation for advanced non-small cell lung cancer.","volume":"32","author":"Bosch-Barrera","year":"2009","journal-title":"Onkologie"},{"key":"R14-19-20210202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy.","volume":"40","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MJT.0b013e3181d860f6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:23:22Z","timestamp":1786040602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201111000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3181d860f6","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}